Cross-examining candidate genes implicated in multiple system atrophy

[1]  T. Raj,et al.  Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation , 2019, Movement disorders : official journal of the Movement Disorder Society.

[2]  J. Lanciego,et al.  Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine , 2019, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Singleton,et al.  Lysosomal storage disorder gene variants in multiple system atrophy. , 2018, Brain : a journal of neurology.

[4]  H. Shang,et al.  Analysis of GWAS-linked variants in multiple system atrophy , 2018, Neurobiology of Aging.

[5]  C. Gellera,et al.  Multiple system atrophy and CAG repeat length: A genetic screening of polyglutamine disease genes in Italian patients , 2018, Neuroscience Letters.

[6]  K. Xia,et al.  Analysis of (CAG)n expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy , 2018, Scientific Reports.

[7]  K. Xia,et al.  Association of TNF-α rs1799964 and IL-1β rs16944 polymorphisms with multiple system atrophy in Chinese Han population , 2018, The International journal of neuroscience.

[8]  A. Quattrone,et al.  A new CHCHD2 mutation identified in a southern italy patient with multiple system atrophy. , 2017, Parkinsonism & related disorders.

[9]  H. Houlden,et al.  Multiple system atrophy: genetic risks and alpha-synuclein mutations , 2017, F1000Research.

[10]  Ichigaku Takigawa,et al.  Genomic copy number variation analysis in multiple system atrophy , 2017, Molecular Brain.

[11]  K. Marder,et al.  Frequency of GBA Variants in Autopsy‐proven Multiple System Atrophy , 2017, Movement disorders clinical practice.

[12]  M. Islam,et al.  Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. , 2017, Biochemical Society transactions.

[13]  S. Cavallaro,et al.  Copy number variability in Parkinson’s disease: assembling the puzzle through a systems biology approach , 2016, Human Genetics.

[14]  Sonja W. Scholz,et al.  A genome-wide association study in multiple system atrophy , 2016, Neurology.

[15]  P. Navas,et al.  The COQ2 genotype predicts the severity of coenzyme Q10 deficiency. , 2016, Human molecular genetics.

[16]  S. Cavallaro,et al.  Copy Number Variants in Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.

[17]  Xinglong Yang,et al.  Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis , 2016, Journal of the Neurological Sciences.

[18]  R. Petersen,et al.  MAPT haplotype diversity in multiple system atrophy. , 2016, Parkinsonism & related disorders.

[19]  T. Matsukawa,et al.  Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy. , 2016, JAMA neurology.

[20]  H. Shang,et al.  C9ORF72 repeat expansions in Chinese patients with Parkinson’s disease and multiple system atrophy , 2016, Journal of Neural Transmission.

[21]  L. Bodea,et al.  Tau physiology and pathomechanisms in frontotemporal lobar degeneration , 2016, Journal of neurochemistry.

[22]  Xiao-Shuang Wu,et al.  Mutations of glucocerebrosidase gene and susceptibility to Parkinson’s disease: An updated meta-analysis in a European population , 2016, Neuroscience.

[23]  K. Jellinger,et al.  Multiple system atrophy: pathogenic mechanisms and biomarkers , 2016, Journal of Neural Transmission.

[24]  E. Masliah,et al.  Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum , 2016, Journal of neuropathology and experimental neurology.

[25]  K. Abe,et al.  New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy , 2016, Neurology: Genetics.

[26]  Xinglong Yang,et al.  Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case–control study and meta-analysis of the literature , 2016, Neurological Sciences.

[27]  G. Wenning,et al.  Review: Multiple system atrophy: emerging targets for interventional therapies , 2016, Neuropathology and applied neurobiology.

[28]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[29]  W. Chung,et al.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. , 2015, Brain : a journal of neurology.

[30]  J. Hardy,et al.  Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation , 2015, Molecular Neurodegeneration.

[31]  Wei Song,et al.  Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population , 2015, PloS one.

[32]  K. Xia,et al.  C9orf72 hexanucleotide expansion analysis in Chinese patients with multiple system atrophy. , 2015, Parkinsonism & related disorders.

[33]  W. Ni,et al.  Mutation Analysis of COQ2 in Chinese Patients with Cerebellar Subtype of Multiple System Atrophy , 2015, CNS neuroscience & therapeutics.

[34]  Henning Urlaub,et al.  Tau stabilizes microtubules by binding at the interface between tubulin heterodimers , 2015, Proceedings of the National Academy of Sciences.

[35]  J. Trojanowski,et al.  Variants associated with Gaucher disease in multiple system atrophy , 2015, Annals of clinical and translational neurology.

[36]  A. Singleton,et al.  Multiple system atrophy: the application of genetics in understanding etiology , 2015, Clinical Autonomic Research.

[37]  A. Singleton,et al.  The analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism☆ , 2015, Neurobiology of Aging.

[38]  Wei Song,et al.  Mutation scanning of the COQ2 gene in ethnic Chinese patients with multiple-system atrophy , 2015, Neurobiology of Aging.

[39]  H. Shang,et al.  An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. , 2015, Parkinsonism & related disorders.

[40]  Sonja W. Scholz,et al.  Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions , 2015, Neurobiology of Aging.

[41]  A. Singleton,et al.  LRRK2 exonic variants and risk of multiple system atrophy , 2014, Neurology.

[42]  S. Ichinose,et al.  Relocation of p25α/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy , 2014, Acta neuropathologica communications.

[43]  A. Paetau,et al.  A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology , 2014, Neurobiology of Aging.

[44]  R. Krüger,et al.  Mutant COQ2 in multiple-system atrophy. , 2014, The New England journal of medicine.

[45]  J. Haines,et al.  Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels , 2014, Alzheimer's Research & Therapy.

[46]  D. Geschwind,et al.  The Neurogenetics of Atypical Parkinsonian Disorders , 2014, Seminars in Neurology.

[47]  A. Singleton,et al.  LRRK2: Cause, Risk, and Mechanism , 2014, Journal of Parkinson's disease.

[48]  Marcus C. Ferguson,et al.  SHC2 gene copy number in multiple system atrophy (MSA) , 2014, Clinical Autonomic Research.

[49]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[50]  J. Hardy,et al.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.

[51]  K. Xia,et al.  Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China , 2013, Journal of Clinical Neuroscience.

[52]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[53]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[54]  M. Emi,et al.  Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy , 2011, Molecular Brain.

[55]  Ji Young Yun,et al.  Survival of Korean patients with multiple system atrophy , 2011, Movement disorders : official journal of the Movement Disorder Society.

[56]  M. Farrer,et al.  MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy , 2011, Neurology.

[57]  G. Halliday,et al.  Glia: Initiators and progressors of pathology in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[58]  Y. Itoyama,et al.  Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy , 2010, Neurochemistry International.

[59]  M. T. Pellecchia,et al.  Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry , 2010, Movement disorders : official journal of the Movement Disorder Society.

[60]  S. Dimauro,et al.  Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  M. Toft,et al.  Copy number variation in Parkinson's disease , 2010, Genome Medicine.

[62]  E. Masliah,et al.  Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors , 2010, The Journal of Neuroscience.

[63]  Christopher Lawrence,et al.  DEGENERATION , 2020, Side Effects May Include Strangers.

[64]  Nicholas W. Wood,et al.  Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy , 2009, PloS one.

[65]  Sonja W. Scholz,et al.  SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.

[66]  Sonja W. Scholz,et al.  GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED CASES OF MULTIPLE SYSTEM ATROPHY , 2009, Neurology.

[67]  Carlos Cruchaga,et al.  5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration , 2009, Neurobiology of Disease.

[68]  N. Quinn,et al.  Survival in multiple system atrophy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[69]  J. Nutt,et al.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease , 2007, Annals of neurology.

[70]  J. Jankovic,et al.  G2019S mutation in the leucine‐rich repeat kinase 2 gene is not associated with multiple system atrophy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[71]  D. Mash,et al.  Causes of death in multiple system atrophy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[72]  J. Lupski,et al.  Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders , 2006, Neuron.

[73]  D. Hernandez,et al.  The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases , 2005, Neuroscience Letters.

[74]  J. Trojanowski,et al.  Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal Degeneration , 2005, Neuron.

[75]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[76]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[77]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[78]  M. Zigmond,et al.  A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis , 2002, The Journal of Neuroscience.

[79]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[80]  Y Ben-Shlomo,et al.  Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.

[81]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[82]  Shigeo Hirai,et al.  NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy , 1998, Acta Neuropathologica.

[83]  P. Blumbergs,et al.  Multiple-system atrophy: a new α-synuclein disease? , 1998, The Lancet.

[84]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[85]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[86]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[87]  D. Maraganore,et al.  Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 , 1997, Neurology.

[88]  P. Lantos,et al.  Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease , 1997, Neuroscience Letters.

[89]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[90]  A. Roses,et al.  The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. , 1995, Genomics.

[91]  H. Yamaguchi,et al.  Oligodendroglial Microtubular Tangles in Olivopontocerebellar Atrophy , 1990, Journal of neuropathology and experimental neurology.

[92]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[93]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[94]  D. Hernandez,et al.  Genome-wide estimate of the heritability of Multiple System Atrophy. , 2016, Parkinsonism & related disorders.

[95]  M. Farrer,et al.  Mutant COQ2 in multiple-system atrophy. , 2014, The New England journal of medicine.

[96]  J. Trojanowski,et al.  Mutations in COQ2 in familial and sporadic multiple-system atrophy. , 2013, The New England journal of medicine.

[97]  N. Quinn,et al.  Difference in MSA phenotype distribution between populations: genetics or environment? , 2012, Journal of Parkinson's disease.

[98]  S. Kato,et al.  Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies , 2004, Acta Neuropathologica.

[99]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[100]  M. Zigmond,et al.  A role for alpha-synuclein in the regulation of dopamine biosynthesis. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[101]  P. Blumbergs,et al.  Multiple-system atrophy: a new alpha-synuclein disease? , 1998, Lancet.

[102]  K. Arima,et al.  NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. , 1998, Acta neuropathologica.

[103]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[104]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.